ºÚÁϳԹÏÍø

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • ºÚÁϳԹÏÍø News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, May 13 2019

Full Issue

Opioid Litigation Divides Sackler Family Over How To Respond To Charges It Bears Responsibility For Deadly Epidemic

As communities seek billions in settlements, the family that owns OxyContin-maker Purdue Pharma is reportedly growing uneasy about defense tactics and charges of misleading marketing. Other news on the drug epidemic looks at a new CDC report on cocaine and meth deaths and unethical practices by a Delaware physician.

A united front among members of the billionaire Sackler family behind painkiller OxyContin is showing signs of strain from litigation over who bears responsibility for the deadly U.S. opioid epidemic. At least twice in recent months, eight members of the Sackler family who own OxyContin maker Purdue Pharma LP have been at odds over how to respond to allegations implicating them in deceptive marketing of prescription painkillers that led to widespread fatal overdoses, said people familiar with the matter. (5/10)

In a drug overdose epidemic that has killed more than 700,000 Americans since 1999, state and local officials have been primarily concentrating on opioids, which were involved in nearly 70% of overdose deaths in 2017. The CDC’s new analysis indicates that public health and law enforcement officials should be just as vigilant when it comes to cocaine, meth and other prescription and illicit drugs of abuse in their communities. (Vestal, 5/13)

Delaware has permanently revoked the license of a doctor accused of prescribing opioids in exchange for sexual favors from a female patient undergoing treatment for long-term drug addiction. The News Journal of Wilmington reports the state Board of Medical Licensure and Discipline this week revoked the license of Nihar B. Gala, who oversaw the pain management and addiction treatment center Alpha Care Medical. (5/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • ºÚÁϳԹÏÍø
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF